Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q1 EPS of $0.44, in-line with the analyst estimate of $0.44. Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE